Log in

Relevant bibliographies by topics / Oral Administration

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Oral Administration'

Author: Grafiati

Published: 4 June 2021

Last updated: 12 April 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Oral Administration.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Oral Administration"

1

Rollwagen, Florence M., and Shahida Baqar. "Oral cytokine administration." Immunology Today 17, no. 12 (December 1996): 548–50. http://dx.doi.org/10.1016/s0167-5699(96)30065-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Fidler, I. J., W. E. Fogler, A. F. Brownbill, and G. Schumann. "Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide." Journal of Immunology 138, no. 12 (June 15, 1987): 4509–14. http://dx.doi.org/10.4049/jimmunol.138.12.4509.

Full text

Abstract:

Abstract The purpose of these studies was to determine whether the oral administration of a lipophilic analog of muramyl dipeptide, MTP-PE, can produce in situ activation of tumoricidal properties in mouse macrophages. MTP-PE was dissolved in a phosphate-buffered saline to produce micelles. Single or multiple oral administrations of MTP-PE produced tumoricidal activation in both lung and peritoneal macrophages. This was in direct contrast to the i.v. or i.p. administrations of MTP-PE incorporated in liposomes, which produced activation in only lung or only peritoneal macrophages, respectively. The distribution and fate of [3H]-labeled MTP-PE subsequent to oral administration revealed that MTP-PE was found in various organs independent of reticuloendothelial activity. Finally, the repeated twice-weekly oral administrations of MTP-PE inhibited lung and lymph node metastasis in C57BL/6 mice by syngeneic B16 melanoma cells. The oral administration of MTP-PE, however, was not effective in eradicating well-established melanoma metastases. We conclude that the oral administration of a lipophilic muramyl dipeptide produces systemic activation of macrophages. The feasibility of enhancing host defense against infections and cancer by the oral administration of an immunomodulator has obvious clinical advantages.

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "Fentanyl - oral transmucosal administration vs oral solution." Inpharma Weekly &NA;, no. 804 (September 1991): 20. http://dx.doi.org/10.2165/00128413-199108040-00053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Falk, John L., and Maisy Tang. "Midazolam oral self-administration." Drug and Alcohol Dependence 15, no. 1-2 (May 1985): 151–63. http://dx.doi.org/10.1016/0376-8716(85)90039-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Davis, Janelle L., Hunter L. Paris, Joseph W. Beals, Scott E. Binns, Gregory R. Giordano, Rebecca L. Scalzo, Melani M. Schweder, Emek Blair, and Christopher Bell. "Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect against Ischemia–Reperfusion Injury." Nutrition and Metabolic Insights 9 (January 2016): NMI.S39764. http://dx.doi.org/10.4137/nmi.s39764.

Full text

Abstract:

Intravenous administration of vitamin C has been shown to decrease oxidative stress and, in some instances, improve physiological function in adult humans. Oral vitamin C administration is typically less effective than intravenous, due in part to inferior vitamin C bioavailability. The purpose of this study was to determine the efficacy of oral delivery of vitamin C encapsulated in liposomes. On 4 separate randomly ordered occasions, 11 men and women were administered an oral placebo, or 4 g of vitamin C via oral, oral liposomal, or intravenous delivery. The data indicate that oral delivery of 4 g of vitamin C encapsulated in liposomes (1) produces circulating concentrations of vitamin C that are greater than unencapsulated oral but less than intravenous administration and (2) provides protection from ischemia–reperfusion-mediated oxidative stress that is similar to the protection provided by unencapsulated oral and intravenous administrations.

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Oral dissolution vs oral administration in hypertensive crises." Inpharma Weekly &NA;, no. 818 (December 1991): 10–11. http://dx.doi.org/10.2165/00128413-199108180-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Robison, Jeanne M., Diana J. Wilkie, and Bethaney Campbell. "SUBLINGUAL AND ORAL MORPHINE ADMINISTRATION." Nursing Clinics of North America 30, no. 4 (December 1995): 725–43. http://dx.doi.org/10.1016/s0029-6465(22)00117-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

DAVIES, R. J., A. C. BAGNALL, R. N. McCABE, M. A. CALDERON, and J. H. WANG. "Antihistamines: topical vs oral administration." Clinical & Experimental Allergy 26 (May 1996): 11–17. http://dx.doi.org/10.1111/j.1365-2222.1996.tb00653.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

&NA;, &NA;. "Oral Medication Administration with RxMediBottle." Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 14, no. 6 (June 1996): 482. http://dx.doi.org/10.1097/00004045-199606000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Oral cephalexin administration equals IV." Inpharma Weekly &NA;, no. 753 (September 1990): 12. http://dx.doi.org/10.2165/00128413-199007530-00036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Oral Administration"

1

Wong, Lai Pun. "Controlled-release matrices for oral administration." Thesis, Queen's University Belfast, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Malina, Kevin. "Evaluation of oral fluoroquinolone administration before and after implementation of electronic prepared medication administration record." The University of Arizona, 2012. http://hdl.handle.net/10150/623659.

Full text

Abstract:

Class of 2012 Abstract
Specific Aims: Determine the incidence of scheduled co-administration times in handwritten (paper) and electronic prepared medication administration records of oral ciprofloxacin and oral moxifloxacin with interacting substances that can affect fluoroquinolone gastrointestinal absorption. Also, determine the incidence of actual co-administration of oral ciprofloxacin and moxifloxacin with interacting substances that can affect fluoroquinolone gastrointestinal absorption with electronic and handwritten prepared medication administration records. Methods: Retrospective data was obtained by a chart review of patients from an academic medical center for a one month period before (May 2010) and after (August 2010) implementation of an electronic prepared medical administration record system. The scheduled time and actual time given for all fluoroquinolone antibiotics, as well as all possible interacting substances, were recorded. Main Results: A total of 99 subjects were included in this study (36 paper and 63 electronic). There was no statistical difference (p=0.47) between the percentage of scheduling errors for the electronic prepared medication administration records, 25.3%, compared to the paper medication administration records, 22.1%. However, there was a decrease in the percentage of actual co-administrations of fluoroquinolones with interacting substances for the electronic prepared MARs compared to paper prepared medication administration records; 22.3% and 32.1% respectfully (p=0.03). Conclusions: After implementing electronic prepared medication administration records at an academic institution, co-administration errors went down even though the amount of scheduling errors did not decrease.

APA, Harvard, Vancouver, ISO, and other styles

3

Malina, Kevin, Kathryn Matthias, and Kurt Weibel. "Evaluation of Oral Fluoroquinolone Administration Before and After Implementation of Electronic Prepared Medication Administration Record." The University of Arizona, 2012. http://hdl.handle.net/10150/614519.

Full text

Abstract:

Class of 2012 Abstract
Specific Aims: Determine the incidence of scheduled co-administration times in handwritten (paper) and electronic prepared medication administration records of oral ciprofloxacin and oral moxifloxacin with interacting substances that can affect fluoroquinolone gastrointestinal absorption. Also, determine the incidence of actual co-administration of oral ciprofloxacin and moxifloxacin with interacting substances that can affect fluoroquinolone gastrointestinal absorption with electronic and handwritten prepared medication administration records. Methods: Retrospective data was obtained by a chart review of patients from an academic medical center for a one month period before (May 2010) and after (August 2010) implementation of an electronic prepared medical administration record system. The scheduled time and actual time given for all fluoroquinolone antibiotics, as well as all possible interacting substances, were recorded. Main Results: A total of 99 subjects were included in this study (36 paper and 63 electronic). There was no statistical difference (p=0.47) between the percentage of scheduling errors for the electronic prepared medication administration records, 25.3%, compared to the paper medication administration records, 22.1%. However, there was a decrease in the percentage of actual co-administrations of fluoroquinolones with interacting substances for the electronic prepared MARs compared to paper prepared medication administration records; 22.3% and 32.1% respectfully (p=0.03). Conclusions: After implementing electronic prepared medication administration records at an academic institution, co-administration errors went down even though the amount of scheduling errors did not decrease.

APA, Harvard, Vancouver, ISO, and other styles

4

Al, Sukhun Rajaa Abed El-Kader. "Lipid drug delivery systems and their fate after oral administration." Thesis, University of Bath, 2002. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.665369.

Full text

Abstract:

A novel class of lipid formulation was investigated comprising GRAS (generally regarded as safe) materials. The formulations were all ‘surfactant-free’ (S-F) formulations, and also referred to as ‘Type IV’ lipid formulations. These formulations were isotropic, transparent, thermodynamically stable at room temperature and typically composed of > 50 % of mixed mono-, di- and triglycerides, > 30 % medium chain fatty acids oil and < 20 % hydrophilic co-solvent. At equilibrium, S-F formulations enhanced the solvent capacity of corticosteroids (log P > 3) and hydroxy benzoate derivatives over type II SEDDS and type III SEDDS, but generally were not superior solvents to mixtures of mono-, di- and triglycerides (Imwitor 988® and or Capmul MCM®) alone, for lipophilic steroids (log P < 3). In general, type III SEDDS which were composed of high hydrophilic content (hydrophilic surfactant, HLB > 1 2 , and hydrophilic co-solvent), were also better solvents for most steroidal compounds and hydroxy benzoate derivatives than type II SEDDS and type I SEDDS formulations. Surfactant with HLB > 12 inhibited lipolysis of MCT and mixed glycerides when the concentration of surfactant exceeded 40 % w/w. Hydrophobic surfactants (HLB < 10) did not inhibit lipolysis. Thus, the digestibility of dispersions formed by selfemulsifying systems would be dependent on the surfactants used and the quantity of TG available for lipolysis. Co-solvents did not appear to influence lipolysis, once the formulations had dispersed. Phase separation of lipid formulations following their dispersion in simulated intestinal fluid was studied. The lipid formulation behaviour was dependent on monoglyceride content. When sufficient monoglyceride (> 60 %w/v) was present demulsification and phase separation was noticed and was found to be dependent on the presence of phospholipid. This resulted in sedimentation of the phase rich V monoglyceride and water. The presence of triglyceride stabilised the formation of mixed micelles, which remained in a finely dispersed state. This unexpected phase separation is likely to have a considerable effect on the fate of drug dissolved in SEDDS formulations. The high concentrations of monoglyceride may be disadvantageous and could possibly result in precipitation of drug.

APA, Harvard, Vancouver, ISO, and other styles

5

Rathman, Sara C. "Effects of oral carbamazepine administration on biotin metabolism in rats." [Gainesville, Fla.] : University of Florida, 2003. http://purl.fcla.edu/fcla/etd/UFE0001103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mauludin, Rachmat [Verfasser]. "Nanosuspensions of poorly soluble drugs for oral administration / Rachmat Mauludin." Berlin : Freie Universität Berlin, 2009. http://d-nb.info/102346568X/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Metzler, Barbara. "Downregulation of systemic immune responses by oral and intranasal antigen administration." Thesis, University of Cambridge, 1994. https://www.repository.cam.ac.uk/handle/1810/270425.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cai, Bing. "Ceramic Materials for Administration of Potent Drugs." Doctoral thesis, Uppsala universitet, Tillämpad materialvetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-245031.

Full text

Abstract:

This thesis aimed to investigate and document the potential of applying ceramics in two specific drug delivery applications: tamper-resistant opioid formulations and transdermal enhancement protrusions. Geopolymers were developed into the matrix for a tamper-resistant formulation, aiming to protect drug substances from non-medical abuse. The synthesis conditions and excipients composition of the geopolymer-based formulation were modified in this work to facilitate a stable and extended drug delivery. Results showed that 37ºC 100% humidity for 48 hours were applicable conditions to obtain geopolymer with suitable mechanical strength and porosity. Moreover, it was found that the integration of poly(methyl acrylate) into the geopolymer-based formulation could reduce the drug release at low pH and, meanwhile, maintain the mechanical strength. Therefore, the geopolymer-based drug formulations concluded from these studies were applied in oral and transdermal delivery systems. Evidence of the tamper-resistance of geopolymer-based oral and transdermal formulations was documented and compared to the corresponding commercial opioid formulations. The results provided experimental support for the positive effects of geopolymers as drug carriers for the tamper-resistance of oral and transdermal delivery systems. Self-setting bioceramics, calcium phosphate and calcium sulfate were fabricated into transdermal enhancement protrusions in this work for the first time. Results showed that, under mild conditions, both bioceramics could form pyramid-shaped needles in the micron size. The drug release from these needles could be controlled by the bulk surface area, porosity and degradation of the bioceramics. An in vitro insertion test showed that the bioceramic microneedles had enough mechanical strength to insert into skin. Further optimization on the geometry of needles and the substrate material was also performed. The higher aspect-ratio needles with a flexible and self-swellable substrate could release most of the drug content within 4 hours and could penetrate through the stratum corneum by manual insertion. This study explored the potential application of bioceramics in transdermal enhancement protrusions and showed promising indication of their future developments.

APA, Harvard, Vancouver, ISO, and other styles

9

Lima, Juliana Pego. "Development of Nanoparticles as Low Molecular Weight Heparins Carriers for Oral Administration." Master's thesis, Faculdade de Farmácia da Universidade do Porto, 2007. http://hdl.handle.net/10216/7486.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Binks, Stephen Peter. "Absorption, toxicity and deposition of transition metal based pharmaceuticals following oral administration." Thesis, University of Surrey, 1988. http://epubs.surrey.ac.uk/847165/.

Full text

Abstract:

The aim of this dissertation was to study the absorption, and subsequent toxic side effects of transition metal based pharmaceuticals following oral administration to rats. Administration of cisplatin (30mg/kg), carboplatin (37mg/kg) and iproplatin (42mg/kg) by oral gavage resulted in their rapid absorption so that respective peak blood levels of 2.63mug platinum/ml, 1.48mug platinum/ml and 3.13mug platinum/ml were achieved within 2-4 hours. Approximately 3-4% of the dose was excreted in the urine, but the major route of elimination was the faeces (>75%). This indicated that although rapid, absorption was relatively poor. Absorption was enhanced by employing a period of starvation prior to administration. A series of novel platinum (IV) mixed amines were absorbed to a greater extent than cisplatin and its congeners, carboplatin and iproplatin. However, absorption was somewhat slower with peak blood levels being attained some 24 hours after administration. Of the other transition metal complexes studied, auranofin and ruthenium acetylacetonate were particularly well absorbed so that peak blood levels of 12.53mug gold/ml and 6.4mug ruthenium/ml were achieved respectively. Urinary clearance of the ruthenium complex was especially significant with up to 45% of the administered dose being eliminated by this pathway within 48 hours. In vitro everted gut sac and in situ perfusion techniques confirmed the in vivo finding that cisplatin is absorbed from the small intestine more readily than carboplatin. No evidence for active or carrier-mediated transport was found and kinetic studies confirmed that absorption was by passive diffusion. Toxicology studies after oral administration of cisplatin (57 or 30mg/kg) or carboplatin (282mg/kg) indicated that the toxicities associated with the perenteral use of the complexes would also apply to the oral route. This was exemplified by the fact that oral cisplatin was profoundly nephrotoxic, whereas carboplatin was not. In addition, gastro-intestinal toxicity manifested as acute necrotizing enteritis and ulcerogenicity of the stomach was potentiated by the oral route. Studies in the ferret indicated that cisplatin is significantly more emetogenic than carboplatin. Examination of liver morphology indicated changes, such as mitochondrial swelling and vesiculation of the endoplasmic reticulum, that might indicate a higher incidence of hepatotoxic responses associated with administration of platinum complexes by the oral route. Both cisplatin and carboplatin induced a degree of myelosuppression but the most pronounced haematological lesion associated with oral administration was severe erythrocytosis which occurred as a result of a dehydration related decrease in plasma volume. Electrothermal atomic absorption analysis of tissues excised from cisplatin and carboplatin rats indicated that platinum deposition was highest in the kidney. In an attempt to explain the prolonged retention of cisplatin in this organ, the intracellular location of the compound was studied using electron microprobe analysis and subcellular fractionation. The various lysosome populations of the proximal tubule were identified as sites of concentration of platinum and it was hypothesised that sequestration within these organelles might be an important mechanism of detoxification.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Oral Administration"

1

C, Moellering Robert, ed. Oral cephalosporins. Basel: Karger, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

T, O'Hagan Derek, ed. Novel delivery systems for oral vaccines. Boca Raton: CRC Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Robert, Lester, Hydrick Blair, and Lyndon Baines Johnson Library, eds. Oral histories of the Johnson administration, 1963-1969. Frederick, Md: University Publications of America, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

E, Weeks Lewis, Center for Hospital and Healthcare Administration History., and Hospital Research and Educational Trust., eds. Index to the Hospital administration oral history collection. Chicago, Ill. (840 N. Lake Shore Dr., Chicago, 60611): Hospital Research and Educational Trust, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Robert, Lester, Hydrick Blair, University Publications of America, Inc., and Lyndon Baines Johnson Library, eds. Oral histories of the Johnson administration, 1963-1969. Frederick, Md: University Publications of America, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Guy, Jacquemelle, ed. Le grand oral de l'ENA. Paris: Editions du Mécène, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

B, Dressman J., and Lennernäs Hans, eds. Oral drug absorption: Prediction and assessment. New York: Marcel Dekker, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Defreece, Loistine. Oral history interview with Loistine Defreece, February 16, 1991: Interview M-0034, Southern Oral History Program Collection (#4007). [Chapel Hill, N.C.]: University Library, UNC-Chapel Hill, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Harrigan, Jim. Safe medication practices: Oral and topical meds. Irvine, Calif: Concept Media, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Dominique, Duchêne, Association de pharmacie galénique industrielle., and Swedish Academy of Pharmaceutical Sciences., eds. Buccal and nasal administration as an alternative to parenteral administration: European symposium, Paris, 10 and 11 December 1991. Paris: Editions de Santé., 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Oral Administration"

1

Mizuno, Tooru M., Ashwini Padhi, Naomi Fineberg, Naomi A. Fineberg, Ashwini Padhi, Michael H. Bloch, James F. Leckman, et al. "Oral Self-Administration." In Encyclopedia of Psychopharmacology, 942. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_4439.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Schneeweiss, Adam, and Marija Weiss. "Oral Administration of Nitrates." In Advances in Nitrate Therapy, 96–98. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-97066-5_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Schneeweiss, Adam, and Marija Weiss. "Oral Administration of Nitrates." In Advances in Nitrate Therapy, 115–17. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-75834-8_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gunnell, Karen Anne, and Rebecca Hayley Venables. "Oral formulations." In A Practical Guide to Medicines Administration, 3–30. Abingdon, Oxon ; New York, NY : Routledge, 2018.: Routledge, 2018. http://dx.doi.org/10.4324/9780203732717-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Granero, Luis, and Ana Polache. "Absorption of Drugs after Oral Administration." In Preclinical Development Handbook, 281–321. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2007. http://dx.doi.org/10.1002/9780470249031.ch9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sawada, Yoshitomo, Haruo Shintaku, Tatsuo Nakajima, Takuji Imamura, Yuriko Tsubakio, Chiyo Iwamura, Gen Isshiki, and Toshiaki Ohura. "Oral Administration of Liposomally Entrapped Tetrahydrobiopterin." In Advances in Experimental Medicine and Biology, 271–72. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2960-6_55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hales, R. Thane. "Infections and Antibiotic Administration." In Manual of Minor Oral Surgery for the General Dentist, 255–76. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470344477.ch9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Meisch, Richard A., and Marilyn E. Carroll. "Oral Drug Self-Administration: Drugs as Reinforcers." In Methods of Assessing the Reinforcing Properties of Abused Drugs, 143–60. New York, NY: Springer New York, 1987. http://dx.doi.org/10.1007/978-1-4612-4812-5_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Cyders, Melissa A. "Oral Alcohol Administration Methods for Alcohol Research." In Neuromethods, 115–21. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-3267-3_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hedaya, Mohsen A. "Drug Pharmacokinetics Following Single Oral Drug Administration." In Basic Pharmacokinetics, 87–107. 3rd ed. New York: Routledge, 2023. http://dx.doi.org/10.4324/9781003161523-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Oral Administration"

1

Melissari, E., M. F. Scully, C. Parker, R. Hedges, and V. V. Kakkar. "PLASMA FREE PROTEIN S AND OESTROGEN ADMINISTRATION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644295.

Full text

Abstract:

It has been shown that protein S has a cofactor role for the anticoagulant and fibrinolytic activity of activated protein C (APC) and that the free protein S fraction is the main cofactor for the APC. Here we report free protein S levels from three groups of women on oral oestrogen. Group A: Five post menopausal women (36-48 years), on oestradiol valerate (as hormone replacement therapy after hysterectomy-oophorectomy) mean free protein S was 62.8% ( 2SD below normal adult mean). Group B: Seven young women (20-25 years) on the contraceptive pill. Two had normal levels of free protein S (100% and 125%), whereas the other five were 30%, 29%, 50%, 60% and 64% of normal. Group C: Two young women. The first, a 25 year old, insulin-dependent diabetic woman developed severe thromboembolic disease shortly after initiation of oral contraception. The second, a 21 year old woman with congenital, moderately decreased plasminogen (PLG) (activity and antigen 45% of normal), had a severe ileofemoral deep venous thrombosis about 8 months after initiation of oral contraceptive (her free protein S levels were twice found to be 60% of normal). In both cases, family members with reduced levels of PK and PLG respectively were free from any thromboembolic disease and had normal protein S levels. Since an association between oral contraceptive use and incidence of venous thromboembolism without predisposition has been consistently observed in case-control and cohort Studies, we conclude that oestrogen may reduce the plasma free protein S concentration and increase thrombophilia.

APA, Harvard, Vancouver, ISO, and other styles

2

Saikat Kumar Jana, Baidyanath Chakravarty, and Koel Chaudhury. "Does oral antioxidant administration improve semen parameters in infertile men?" In 2010 International Conference on Systems in Medicine and Biology (ICSMB). IEEE, 2010. http://dx.doi.org/10.1109/icsmb.2010.5735412.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Xi, Ning, Yingjun Zhang, Zhaohe Wang, Taoxi Lin, and Qian Wang. "Abstract 2532: Vemurafenib prodrugs suitable for oral and IV administration." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Moreira, Stella, Wandemberg Neto, Gabriela Lourenço, Carla Costa, Sávio Araújo, and Daniela Barros. "Anxiolytic effects of oral administration of L-Theanine: a revision." In MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition. Basel, Switzerland: MDPI, 2018. http://dx.doi.org/10.3390/mol2net-04-05543.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Taylor-Cousar, Jennifer L., Connie G. St. Clair, Marion C. Jones, David P. Nichols, Milene Saavedra, Jerry A. Nick, and Linda A. Felton. "Pharmacokinetics Of Oral Sildenafil Administration In Subjects With Cystic Fibrosis." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Larghi, Enrique L., María A. Operto, Andrea V. Coscia, René Torres, and Teodoro S. Kaufman. "Chemical Modifications on Filifolinol. New Derivatives Potentially Suitable for Oral Administration." In 14th Brazilian Meeting on Organic Synthesis. São Paulo: Editora Edgard Blücher, 2013. http://dx.doi.org/10.5151/chempro-14bmos-r0386-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pereira, Rosa, Tommy Julianto, Kah Yuen, and Abu Abdul Majeed. "Anionic Eudragit nanoparticles as carriers for oral administration of peptidomimetic drugs." In 2006 International Conference on Nanoscience and Nanotechnology. IEEE, 2006. http://dx.doi.org/10.1109/iconn.2006.340611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lu, C., and R. Fenske. "274. Salivary Excretion of the Herbicide, Atrazine, After Oral Administration in Rats." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2764944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Molina, M., A. Rossignoli, S. de-Andrés, M. Moro, M. Ruano, P. Gabaldón, C. Jiménez, and A. Herrero. "5PSQ-108 Reducing errors of oral medication administration in patients with dysphagia." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.461.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Meca, N., A. Manzaneque, G. Castells, G. Garreta, C. Sebastián, I. Parés, P. Arcenillas, and J. Nicolás. "4CPS-185 Administration of oral anticancer drugs for patients with swallowing difficulties." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.286.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Oral Administration"

1

Johnson, Anna K., Roy A. Edler, J. Tyler Holck, Brad V. Lawrence, and Robert G. Baker. Drinking Behavior of Nursery Pigs for Oral Vaccine Administration. Ames (Iowa): Iowa State University, January 2007. http://dx.doi.org/10.31274/ans_air-180814-626.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Klein, Laura C. Stress, Predictability, and Oral Fentanyl Self-Administration in Female and Male Rats. Fort Belvoir, VA: Defense Technical Information Center, February 1995. http://dx.doi.org/10.21236/ad1011448.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Orner, Gayle A., Danley F. Brown, Jr Korte, and Don W. Circulatory and Hematological Effects of Liquid Propellant 1846 Following Oral Administration to Rats. Fort Belvoir, VA: Defense Technical Information Center, June 1988. http://dx.doi.org/10.21236/ada198046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shibata, Yoshimi. Oral Administration of N-Acetyl-D Glucosamine Polymer Particles Down-Regulates Airway Allergic Responses. Fort Belvoir, VA: Defense Technical Information Center, March 2005. http://dx.doi.org/10.21236/ada442684.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Shibata, Yoshimi. Oral Administration of N-acetyl-D Glucosamine Polymer Particles Down-Regulates Airway Allergic Responses. Fort Belvoir, VA: Defense Technical Information Center, May 2008. http://dx.doi.org/10.21236/ada484241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Shibata, Yoshimi. Oral Administration of N-Acetyl-D Glucosamine Polymer Particles Down-Regulates Airway Allergic Responses. Fort Belvoir, VA: Defense Technical Information Center, March 2006. http://dx.doi.org/10.21236/ada454070.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Shibata, Yoshimi. Oral Administration of N-Acetyl-D-Glucosamine Polymer Particles Down-Regulates Airway Allergic Responses. Fort Belvoir, VA: Defense Technical Information Center, March 2007. http://dx.doi.org/10.21236/ada469207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shibata, Yoshimi. Oral Administration of a N-Acetyl-D-Glucosamine Polymer Particles Down-Regulates Airway Allergic Responses. Fort Belvoir, VA: Defense Technical Information Center, March 2004. http://dx.doi.org/10.21236/ada424227.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

wang, xiaoxue, Xiang Pu, Guanwei Fan, Xia Chen, ying Tang, nana wu, and jiangli luo. Clinical Effectiveness and Safety of TCM Oral Administration for the Treatment of Allergic Contact Dermatitis: A Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2023. http://dx.doi.org/10.37766/inplasy2023.11.0037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

MAO, Zhiyuan, Qingyu XIE, Yang SU, Ziyi SHEN, Jiahui HU, and Yewen SUN. Meta-analysis of the effect of oral administration and external application of traditional Chinese medicine on reducing blood uric acid level in patients with gout. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!